IntelGenx Enters into Feasibility & Development Agreement For CBD-Infused VetaFilm™ – World News Report
/EIN News/ — SAINT LAURENT, Quebec, Nov. 09, 2022 (GLOBE NEWSWIRE) — IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”), a leader in pharmaceutical films, today announced that it has entered into a Feasibility Study & Development Agreement (the “Agreement”) with an undisclosed animal health company focused on advancing a VetaFilm™-based ... Read More